An Oncology biotech pioneering  RAD51 inhibition to treat high replication stress tumors

Dr. John Bondo Hansen joins Satya’s Advisory Board

Dr. John Bondo Hansen is a seasoned Medicinal Chemist and formally Vice President of Medicinal Chemistry at Novo Nordisk. Dr. Hansen worked in drug discovery in positions of increasing responsibility. He was the co-founder and member of management of several companies including Contera Pharma, which was acquired by Bukwang Pharma of Korea in 2014.
Scroll to Top